People Science is a direct-to-consumer scientific research company in the Health Care industry, founded in 2019. The company’s slogan, "Bringing science to the people - providing clinical research and an R&D marketplace for alternative medicines," captures its mission. People Science offers a scaled R&D platform for alternative medicines, aiming to revolutionize the landscape with its data-driven and consumer-centric approach. Powered by the proprietary software technology CHLOE (Consumer Health Learning and Organizing Ecosystem), People Science integrates clinical care with scientific research, fostering collaboration among patients, consumers, providers, and scientists to improve health outcomes. The company's research marketplace creates a new model of access, participation, and education, connecting patient communities with healthcare providers and scientists in the alternative medicines market. Additionally, People Science provides a seal of approval for companies manufacturing alternative medicines, establishing credibility in the rapidly expanding market. Some examples of alternative medicines in focus include medical cannabis and cannabinoids, microbiome and probiotic interventions, functional medicine and nutritional supplements, and psychedelic medicines. In its latest funding round on 26 January 2023, People Science secured a $5.30M Seed Round investment from prominent investors including Bluestein Ventures, Acre Venture Partners, FORM Life Ventures, and Thia Ventures. Notably, as a for-profit Public Benefit Corporation, People Science seeks partners, clients, and investors aligned with its long-term vision and societal impact. Emphasizing the value it brings to society, People Science presents an intriguing opportunity for potential investors to engage in the rapidly evolving landscape of alternative medicines.
No recent news or press coverage available for People Science.